Core Viewpoint - Longhong High-Tech reported a revenue of 1.843 billion yuan for the first half of 2025, marking a year-on-year increase of 16.25%, while the net profit attributable to shareholders was 1.6766 million yuan, indicating significant challenges in profitability due to macroeconomic factors and operational adjustments [1][2]. Group 1: Financial Performance - In Q2 2025, the company achieved a revenue of 1.125 billion yuan and a net profit of 18.1054 million yuan, successfully turning around from losses in the previous quarter [1]. - The overall net profit for the first half of the year saw a substantial decline compared to the previous year, primarily due to a prolonged technical upgrade at its subsidiary, Longhong Biological, which affected production output [1][2]. Group 2: Operational Developments - Despite the profit decline, Longhong High-Tech made significant progress in key projects, including the completion of the 250,000 tons/year solution styrene-butadiene rubber expansion project and the TPE black masterbatch technical upgrade project [2]. - The company is in the process of acquiring 100% equity of Guangxi Changke, which will expand its product matrix into the specialty synthetic resin sector, enhancing its full-chain layout from basic raw materials to high-end modified materials [2]. Group 3: Product Line Performance - The PBAT/PBT business line maintained growth with a revenue increase of 23.05% and a gross margin improvement of 2.12 percentage points [2]. - The calcium carbonate business emerged as the largest performance highlight, with a revenue increase of 842.33% and a gross margin increase of 11.47 percentage points, benefiting from the scale production phase and high-value products [3]. - The black masterbatch business faced short-term pressure due to technical upgrades but is expected to rebound in performance as market demand continues to recover in the second half of the year [3].